<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02098369</url>
  </required_header>
  <id_info>
    <org_study_id>PCORI-CE 1304-6490</org_study_id>
    <nct_id>NCT02098369</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers</brief_title>
  <acronym>PELICAN</acronym>
  <official_title>Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AlphaNet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Apria Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>COPD Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Los Angeles Biomedical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Jewish Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Association for Respiratory Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using
      O2 can prolong life and increase quality of life. Patients often do not use their oxygen as
      prescribed, which means that they are not benefiting as much as they could be from this
      therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients
      and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and
      improve health in patients with chronic obstructive pulmonary disease (COPD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The COPD Foundation operates a peer-led telephone-based information line, but its
      effectiveness in promoting adherence to O2 therapy and patient-centered outcomes is unknown.
      Our overall hypothesis is that a patient-centered Peer-Led O2 InfoLine for patients and
      CAregivers (PELICAN) will increase adherence and improve health. We have developed a
      broad-based collaboration with patients/caregivers, advocacy groups, a national O2 supplier,
      and others to conduct a 3-arm pragmatic clinical trial, to evaluate the comparative
      effectiveness of proactive vs. reactive PELICAN interventions vs. usual care on adherence to
      O2 (primary outcome) and on other patient-centered outcomes (secondary outcomes).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to supplemental O2 prescription</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute care utilization</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">507</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Written education material (basic)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Proactive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Written education material (basic) Additional education material PELICAN-Proactive [In addition to the usual care, participants will receive educational material and a proactive telephone peer coaching program (coaches call participants)]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reactive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Written education material (basic) Additional education material PELICAN-Reactive [In addition to the usual care, participants will receive educational material and a reactive telephone peer coaching program (participants call coaches)]</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Written education material (basic)</intervention_name>
    <description>Education material on COPD distributed to all participants.</description>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_label>Proactive</arm_group_label>
    <arm_group_label>Reactive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Additional education material</intervention_name>
    <description>Additional education material sent to participants in the proactive and reactive arms.</description>
    <arm_group_label>Proactive</arm_group_label>
    <arm_group_label>Reactive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PELICAN-Proactive</intervention_name>
    <description>In the proactive arm, calls will be initiated by the coach. The phone calls will involve educational and social support components. PELICAN is grounded on the social cognitive theory of behavior change and seeks to improve patient adherence by addressing patient self-efficacy and outcome expectancy.</description>
    <arm_group_label>Proactive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PELICAN-Reactive</intervention_name>
    <description>Participants allocated to the reactive PELICAN group will be offered the opportunity to access the COPD Foundation Infoline toll-free.</description>
    <arm_group_label>Reactive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years or older.

          2. Physician diagnosis of COPD

          3. Physician prescription for home O2 for 24hrs/day, 7 days/week

          4. Willing to use home O2.

          5. Working telephone number.

        Exclusion Criteria:

          1. Unable to read and speak English.

          2. Discharge to home hospice or expected survival less than 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry A Krishnan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Apria Healthcare</name>
      <address>
        <city>Lake Forest</city>
        <state>California</state>
        <zip>92630</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Los Angeles Biomedical Research Institute</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AlphaNet</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>COPD Foundation</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pcori.org/research-results/2013/comparative-effectiveness-peer-led-supplemental-o2-infoline-patients-and</url>
    <description>Patient-Centered Outcomes Research Institute (PCORI): Funding Award details</description>
  </link>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2014</study_first_submitted>
  <study_first_submitted_qc>March 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2014</study_first_posted>
  <last_update_submitted>October 28, 2016</last_update_submitted>
  <last_update_submitted_qc>October 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Jerry Krishnan</investigator_full_name>
    <investigator_title>Professor of Medicine and Public Health; Associate Vice Chancellor for Population Health Sciences</investigator_title>
  </responsible_party>
  <keyword>Chronic obstructive pulmonary disease (COPD)</keyword>
  <keyword>Supplemental oxygen</keyword>
  <keyword>Adherence</keyword>
  <keyword>Telephonic education</keyword>
  <keyword>Peer coaching</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>December 30, 2016</submitted>
    <returned>February 20, 2017</returned>
    <submitted>February 23, 2017</submitted>
    <returned>April 10, 2017</returned>
    <submitted>November 6, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

